A dual GIP/GLP-1 receptor agonist studied for potent glucose control and body-weight reduction in metabolic research models.
Catalog
Every purchase comes with a complete set of everything you would need to start your journey and experience with Syntec PH.
A dual GIP/GLP-1 receptor agonist studied for potent glucose control and body-weight reduction in metabolic research models.
A triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways at once. Among the most potent compounds in research for appetite suppression, glycemic control, and energy expenditure.
All products on this site are designated for Research Use Only and are supplied solely for laboratory, analytical, or scientific research purposes by qualified professionals. Products are not intended for human or animal use, and no diagnostic, therapeutic, or clinical use is intended or implied.
Syntec Philippines is a research-chemical supplier operating under Republic Act 9711 (Food and Drug Administration Act of 2009). We do not manufacture, compound, dispense, or distribute pharmaceuticals, supplements, or health products subject to FDA Philippines registration. Products are supplied solely as analytical reference materials for in vitro research by qualified professionals.